Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A nationwide population-based study.

MLA

Han, Seung Jin, et al. “Effectiveness and Safety of Sodium-Glucose Co-Transporter-2 Inhibitors Compared with Dipeptidyl Peptidase-4 Inhibitors in Older Adults with Type 2 Diabetes: A Nationwide Population-Based Study.” Diabetes, Obesity & Metabolism, vol. 23, no. 3, Mar. 2021, pp. 682–91. EBSCOhost, https://doi.org/10.1111/dom.14261.

APA

Han, S. J., Ha, K. H., Lee, N., & Kim, D. J. (2021). Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A nationwide population-based study. Diabetes, Obesity & Metabolism, 23(3), 682–691. https://doi.org/10.1111/dom.14261

Chicago

Han, Seung Jin, Kyoung Hwa Ha, Nami Lee, and Dae Jung Kim. 2021. “Effectiveness and Safety of Sodium-Glucose Co-Transporter-2 Inhibitors Compared with Dipeptidyl Peptidase-4 Inhibitors in Older Adults with Type 2 Diabetes: A Nationwide Population-Based Study.” Diabetes, Obesity & Metabolism 23 (3): 682–91. doi:10.1111/dom.14261.